ES2114562T3 - Forma de dosificacion para distribucion retardada de farmacos. - Google Patents
Forma de dosificacion para distribucion retardada de farmacos.Info
- Publication number
- ES2114562T3 ES2114562T3 ES92914277T ES92914277T ES2114562T3 ES 2114562 T3 ES2114562 T3 ES 2114562T3 ES 92914277 T ES92914277 T ES 92914277T ES 92914277 T ES92914277 T ES 92914277T ES 2114562 T3 ES2114562 T3 ES 2114562T3
- Authority
- ES
- Spain
- Prior art keywords
- dosage form
- delayed
- pharmacy
- distribution
- pharmacy distribution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feedback Control In General (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Valve Device For Special Equipments (AREA)
- Percussion Or Vibration Massage (AREA)
- Reciprocating, Oscillating Or Vibrating Motors (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE PRESENTA UNA PREPARACION MEDICINAL DE DOSIFICACION (10) QUE CONSTA DE UN ELEMENTO (17) PARA RETARDAR EL SUMINISTRO DE UN FARMACO (16) DE LA PREPARACION MEDICINAL DE DOSIFICACION (16) TRAS LA ADMINISTRACION DE LA PREPARACION MEDICINAL DOSIFICACION (10) A UN PACIENTE QUE NECESITE UNA TERAPIA CON EL FARMACO (16).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/722,622 US5160744A (en) | 1991-06-27 | 1991-06-27 | Verapmil therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2114562T3 true ES2114562T3 (es) | 1998-06-01 |
Family
ID=24902641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92914277T Expired - Lifetime ES2114562T3 (es) | 1991-06-27 | 1992-06-26 | Forma de dosificacion para distribucion retardada de farmacos. |
Country Status (18)
Country | Link |
---|---|
US (1) | US5160744A (es) |
EP (1) | EP0591389B1 (es) |
JP (1) | JP3718522B2 (es) |
KR (1) | KR0137731B1 (es) |
AT (1) | ATE165000T1 (es) |
AU (1) | AU654871B2 (es) |
CA (1) | CA2105165C (es) |
DE (1) | DE69225135T2 (es) |
ES (1) | ES2114562T3 (es) |
FI (1) | FI110919B (es) |
GR (1) | GR3026674T3 (es) |
IE (1) | IE922122A1 (es) |
MX (1) | MX9203443A (es) |
NO (1) | NO306377B1 (es) |
NZ (1) | NZ243343A (es) |
PT (1) | PT100635B (es) |
WO (1) | WO1993000071A1 (es) |
ZA (1) | ZA924772B (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6764697B1 (en) * | 1991-06-27 | 2004-07-20 | Alza Corporation | System for delaying drug delivery up to seven hours |
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
US5854254A (en) * | 1994-03-30 | 1998-12-29 | North Shore University Hospital | Male contraceptives |
US20040191314A1 (en) * | 1994-04-28 | 2004-09-30 | Frank Jao | Antiepileptic dosage form and process for protecting antiepileptic drug |
ZA953078B (en) * | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
US6486177B2 (en) * | 1995-12-04 | 2002-11-26 | Celgene Corporation | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
US5922736A (en) * | 1995-12-04 | 1999-07-13 | Celegene Corporation | Chronic, bolus administration of D-threo methylphenidate |
AU724576B2 (en) * | 1996-06-24 | 2000-09-28 | Merck & Co., Inc. | A composition of enalapril and losartan |
US5788987A (en) | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
ES2125198B1 (es) * | 1997-05-13 | 1999-11-16 | Vita Invest Sa | Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares. |
US6962997B1 (en) * | 1997-05-22 | 2005-11-08 | Celgene Corporation | Process and intermediates for resolving piperidyl acetamide steroisomers |
US6245357B1 (en) * | 1998-03-06 | 2001-06-12 | Alza Corporation | Extended release dosage form |
US8524277B2 (en) * | 1998-03-06 | 2013-09-03 | Alza Corporation | Extended release dosage form |
KR100827254B1 (ko) | 1998-06-03 | 2008-05-07 | 알자 코포레이션 | 연장된 약물 치료를 제공하기 위한 방법 및 장치 |
US6524620B2 (en) | 1998-07-20 | 2003-02-25 | Andrx Pharmaceuticals, Inc. | Diltiazem controlled release formulation and method of manufacture |
UA74141C2 (uk) | 1998-12-09 | 2005-11-15 | Дж.Д. Сірл Енд Ко. | Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти) |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
US20060153914A1 (en) * | 1999-12-10 | 2006-07-13 | Biovail Laboratories International S.R.L. | Chronotherapeutic diltiazem formulations and the administration thereof |
EE200200361A (et) * | 1999-12-23 | 2003-10-15 | Pfizer Products Inc. | Hüdrogeeli-juhitav ravimi doseerimise vahend |
BR0016707A (pt) | 1999-12-23 | 2002-09-03 | Pfizer Prod Inc | Forma de dosagem de droga em camadas acionada por hidrogel |
CA2409437A1 (en) * | 2000-05-11 | 2001-11-22 | Pharmacia Corporation | Aldosterone antagonist composition for release during aldosterone acrophase |
US6488962B1 (en) * | 2000-06-20 | 2002-12-03 | Depomed, Inc. | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
US8329217B2 (en) * | 2001-11-06 | 2012-12-11 | Osmotica Kereskedelmi Es Szolgaltato Kft | Dual controlled release dosage form |
US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
CA2481236A1 (en) * | 2002-03-29 | 2003-10-09 | Alza Corporation | Volume efficient controlled release dosage form |
US20040005359A1 (en) * | 2002-06-27 | 2004-01-08 | Cheng Xiu Xiu | Controlled release oral dosage form |
US20050239830A1 (en) * | 2004-04-26 | 2005-10-27 | Vikram Khetani | Methods of diminishing co-abuse potential |
WO2006046114A2 (en) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Osmotic dosage forms providing ascending drug release, and processes for their preparation |
EP1830648A4 (en) * | 2004-12-09 | 2008-03-12 | Celgene Corp | TREATMENT WITH D-THREO-METHYLPHENIDATE |
DE102005031577A1 (de) | 2005-07-06 | 2007-01-11 | Bayer Healthcare Ag | Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten |
DE102008059206A1 (de) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
CN102091052B (zh) * | 2009-12-15 | 2012-11-07 | 北京协和药厂 | 双环醇双层渗透泵控释片剂及其制备方法 |
CN102293760B (zh) * | 2011-03-04 | 2015-03-18 | 上海医药集团股份有限公司 | 一种单硝酸异山梨酯择时控释制剂及其制备方法 |
EP2846777B1 (en) | 2012-05-07 | 2016-10-26 | Bayer Pharma Aktiengesellschaft | Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil |
UY34856A (es) | 2012-07-03 | 2013-12-31 | Bayer Pharma AG | Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
US4318400A (en) * | 1980-01-18 | 1982-03-09 | Alza Corporation | Medical infusor |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
DE3228502A1 (de) * | 1982-07-30 | 1984-02-02 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung des c1-inaktivators und seine verwendung |
US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
US4765989A (en) * | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
US4863744A (en) * | 1984-09-17 | 1989-09-05 | Alza Corporation | Intestine drug delivery |
US4753802A (en) * | 1986-03-19 | 1988-06-28 | Alza Corporation | Verapamil dosage form |
US4842867A (en) * | 1986-05-09 | 1989-06-27 | Alza Corporation | Pulsed drug delivery of doxylamine |
US4948592A (en) * | 1986-05-09 | 1990-08-14 | Alza Corporation | Pulsed drug delivery |
US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
US4946687A (en) * | 1987-10-02 | 1990-08-07 | Alza Corporation | Dosage form for treating cardiovascular diseases |
US4950486A (en) * | 1987-10-02 | 1990-08-21 | Alza Corporation | Dosage form for treating cardiovascular diseases |
US5019397A (en) * | 1988-04-21 | 1991-05-28 | Alza Corporation | Aqueous emulsion for pharmaceutical dosage form |
US4966769A (en) * | 1988-06-02 | 1990-10-30 | Alza Corporation | Method for delivering dosage form for diltiazem |
IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Hydrogel-operated release devices |
US5019396A (en) * | 1989-05-12 | 1991-05-28 | Alza Corporation | Delivery dispenser for treating cardiac arrhythmias |
US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
-
1991
- 1991-06-27 US US07/722,622 patent/US5160744A/en not_active Expired - Lifetime
-
1992
- 1992-06-26 JP JP50169993A patent/JP3718522B2/ja not_active Expired - Lifetime
- 1992-06-26 AT AT92914277T patent/ATE165000T1/de active
- 1992-06-26 CA CA002105165A patent/CA2105165C/en not_active Expired - Lifetime
- 1992-06-26 ES ES92914277T patent/ES2114562T3/es not_active Expired - Lifetime
- 1992-06-26 AU AU22550/92A patent/AU654871B2/en not_active Expired
- 1992-06-26 NZ NZ243343A patent/NZ243343A/en not_active IP Right Cessation
- 1992-06-26 WO PCT/US1992/005455 patent/WO1993000071A1/en active IP Right Grant
- 1992-06-26 DE DE69225135T patent/DE69225135T2/de not_active Expired - Lifetime
- 1992-06-26 MX MX9203443A patent/MX9203443A/es unknown
- 1992-06-26 EP EP92914277A patent/EP0591389B1/en not_active Expired - Lifetime
- 1992-06-26 PT PT100635A patent/PT100635B/pt not_active IP Right Cessation
- 1992-06-26 ZA ZA924772A patent/ZA924772B/xx unknown
- 1992-07-01 IE IE212292A patent/IE922122A1/en not_active IP Right Cessation
-
1993
- 1993-11-03 KR KR1019930703333A patent/KR0137731B1/ko not_active IP Right Cessation
- 1993-12-09 NO NO934487A patent/NO306377B1/no not_active IP Right Cessation
- 1993-12-23 FI FI935844A patent/FI110919B/fi not_active IP Right Cessation
-
1998
- 1998-04-16 GR GR980400748T patent/GR3026674T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR0137731B1 (ko) | 1998-05-15 |
NO306377B1 (no) | 1999-11-01 |
NO934487D0 (no) | 1993-12-09 |
GR3026674T3 (en) | 1998-07-31 |
JPH06508838A (ja) | 1994-10-06 |
JP3718522B2 (ja) | 2005-11-24 |
PT100635B (pt) | 1999-07-30 |
NO934487L (no) | 1993-12-17 |
FI935844A (fi) | 1993-12-23 |
DE69225135T2 (de) | 1998-08-20 |
PT100635A (pt) | 1993-09-30 |
ATE165000T1 (de) | 1998-05-15 |
MX9203443A (es) | 1992-12-01 |
CA2105165A1 (en) | 1992-12-28 |
AU2255092A (en) | 1993-01-25 |
IE922122A1 (en) | 1992-12-30 |
WO1993000071A1 (en) | 1993-01-07 |
DE69225135D1 (de) | 1998-05-20 |
FI110919B (fi) | 2003-04-30 |
FI935844A0 (fi) | 1993-12-23 |
EP0591389A1 (en) | 1994-04-13 |
ZA924772B (en) | 1993-03-31 |
US5160744A (en) | 1992-11-03 |
CA2105165C (en) | 2004-03-16 |
AU654871B2 (en) | 1994-11-24 |
EP0591389B1 (en) | 1998-04-15 |
NZ243343A (en) | 1994-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2114562T3 (es) | Forma de dosificacion para distribucion retardada de farmacos. | |
KR930007441A (ko) | 의약품 | |
ES2170069T3 (es) | 1-alfa-hidroxiprevitamina d para administracion oral. | |
ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
ES2062779T3 (es) | Forma de dosificacion para suministrar farmacos al intestino. | |
PT957899E (pt) | Forma de dosagem para proporcionar um medicamento numa dose crescente | |
PT932388E (pt) | Forma de dosagem e metodo para administracao de farmacos | |
KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
ZA926241B (en) | Dosage form for delivering drug in short-time period | |
IT8767796A0 (it) | Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo | |
BR122012014331A8 (pt) | Formulações farmacêuticas | |
PT90049A (pt) | Forma de dosagem para administrar um medicamento para terapia humana | |
ES2080307T3 (es) | Composiciones farmaceuticas. | |
NZ229518A (en) | Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment | |
ATE197670T1 (de) | Parenterales busulfan zur behandlung von malignen krankheiten | |
AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
ES2069897T3 (es) | Forma de dosificacion para administrar un farmaco para realizar una terapia circadiana. | |
ES2161809T3 (es) | Uso de factor proliferativo osteoblastico. | |
IT1271354B (it) | Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi | |
RU95110268A (ru) | Способ лечения хронических заболеваний гомеопатическими средствами | |
IT1267664B1 (it) | Composizione a base di fosfocreatina e suo uso farmaceutico | |
RU99125561A (ru) | Способ лечения хронических дерматозов | |
ES1008953Y (es) | Un dispositivo para la reconstitucion y administracion de sustancias terapeuticas a pacientes mediante infusion. | |
IT8940141A0 (it) | Filo medicato per somministrare localmente medicamenti | |
DK117291D0 (da) | Doseringsform til oral indgift af laegemiddelstoffer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 591389 Country of ref document: ES |